 Hi, I'm Dr. Matthew Sable from the Structural Heart and Interventional Cardiology team at Hackensack Morning Health, Jersey Shore University Medical Center. I'm here to give you an update on some recent guideline changes for the management of atrial fibrillation. Historically, patients who have AFib are often treated with a blood thinner to prevent stroke and the main blood thinner available commercially is Coumadin or Warfarin. And as many of you know, taking this medicine comes with the need to monitor blood tests, avoid certain foods, and monitor interactions with several drugs you take. Recently, the ACC and American Heart Association guidelines have changed. There are now four new commercially available drugs for the prevention of stroke in patients with atrial fibrillation. These new drugs may provide decreased risk of bleeding and be more efficacious or beneficial with preventing stroke. If you're interested in learning about these new drugs or other options for stroke prevention in atrial fibrillation, please research your doctor.